{
    "2015-03-02": [
        "AMGN in ABC Bullish Pattern, Targets",
        "Today's pharma news covering NVS, GSK, AMGN, Kyprolis, JNJ, Takeda, Velcade, Gilead Sciences, Natco Pharma",
        "AMGN - Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis (carfilzomib) Over Velcade",
        "AMGN says its study found Kyprolis had double PFS vs Velcade in relapsed multiplemyeloma patients: 18.7 months vs 9"
    ]
}